Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 23, 1998

View Archived Issues

Biovector Planning IPO For 'At Least' FFr200M

Enzyme Structure Reveals Tumor Suppressor Function

Cerebrus, Lilly Team Up To Treat Chemo Emesis

Novartis Scientists Form Company To Target CNS

ExonHit, Rhone-Poulenc Target Tumor Suppressors

Irish Biotech Starving For Cash, Leaders Say

Cortecs Trims Spending, Denies Financing Rumors

Vanguard To Drop Drugs After Phase II Studies

Limagrain Forms Spin-Off; Investor Talks Under Way

EU Patents Directive Becoming A Reality

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.